[1] Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol, 2023; 79, 1542−56. doi:  10.1016/j.jhep.2023.06.003
[2] Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut, 2024; 73, 691−702. doi:  10.1136/gutjnl-2023-330595
[3] Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol, 2025; 31, S32−50. doi:  10.3350/cmh.2024.0431
[4] Huang XJ, Yu RL, Tan XY, et al. Comparison of NAFLD, MAFLD, and MASLD prevalence and clinical characteristics in Asia adults. J Clin Exp Hepatol, 2025; 15, 102420. doi:  10.1016/j.jceh.2024.102420
[5] Liu ZQ, Huang JY, Dai LJ, et al. Steatotic liver disease prevalence in China: a population-based study and meta-analysis of 17.4 million individuals. Aliment Pharmacol Ther, 2025; 61, 1110−22. doi:  10.1111/apt.70051
[6] Liu JY, Ayada I, Zhang XF, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol, 2022; 20, e573−82. doi:  10.1016/j.cgh.2021.02.030
[7] Sakurai Y, Kubota N, Yamauchi T, et al. Role of insulin resistance in MAFLD. Int J Mol Sci, 2021; 22, 4156. doi:  10.3390/ijms22084156
[8] Foulds CE, Treviño LS, York B, et al. Endocrine-disrupting chemicals and fatty liver disease. Nat Rev Endocrinol, 2017; 13, 445−57. doi:  10.1038/nrendo.2017.42
[9] Sun JC, Fang RC, Wang H, et al. A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: where exposomics meets metabolomics. Environ Int, 2022; 158, 106941. doi:  10.1016/j.envint.2021.106941
[10] Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr Rev, 2009; 30, 293−342. doi:  10.1210/er.2009-0002
[11] Yilmaz B, Terekeci H, Sandal S, et al. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention. Rev Endocr Metab Disord, 2020; 21, 127−47. doi:  10.1007/s11154-019-09521-z
[12] Guo Y, Guan X, You YT, et al. Association between organochlorine pesticides and metabolic dysfunction-associated steatotic liver disease: findings from the Dongfeng-Tongji cohort. Environ Int, 2025; 201, 109571. doi:  10.1016/j.envint.2025.109571
[13] Yang RC, Jiang QQ, Liu WT, et al. Serum polychlorinated biphenyls as a risk factor for MASLD: exploring the association and underlying mechanisms. Sci Total Environ, 2025; 981, 179617. doi:  10.1016/j.scitotenv.2025.179617
[14] Pravednikov A, Perkovic S, Lagerkvist CJ. Main factors influencing the perceived health risk of endocrine-disrupting chemicals: a systematic literature review. Environ Res, 2024; 262, 119836. doi:  10.1016/j.envres.2024.119836
[15] Valenti L, Corradini E, Adams LA, et al. Consensus statement on the definition and classification of metabolic hyperferritinaemia. Nat Rev Endocrinol, 2023; 19, 299−310. doi:  10.1038/s41574-023-00807-6
[16] Fonseca Ó, Ramos AS, Gomes LTS, et al. New perspectives on circulating ferritin: its role in health and disease. Molecules, 2023; 28, 7707. doi:  10.3390/molecules28237707
[17] Gao H, Jin ZM, Bandyopadhyay G, et al. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis. Cell Metab, 2022; 34, 1201-13. e5.
[18] Gensluckner S, Wernly B, Datz C, et al. Iron, oxidative stress, and metabolic dysfunction—associated steatotic liver disease. Antioxidants (Basel), 2024; 13, 208. doi:  10.3390/antiox13020208
[19] Shen X, Yu ZQ, Wei CL, et al. Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step? Am J Physiol Endocrinol Metab, 2024; 326, E767-75.
[20] Mayneris-Perxachs J, Cardellini M, Hoyles L, et al. Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. Microbiome, 2021; 9, 104. doi:  10.1186/s40168-021-01052-7
[21] Lin CY, Lee HL, Wang CK, et al. Examining the impact of polyfluoroalkyl substance exposure on erythrocyte profiles and its related nutrients: insights from a prospective study on young Taiwanese. Environ Pollut, 2024; 359, 124576. doi:  10.1016/j.envpol.2024.124576
[22] Omoike OE, Pack RP, Mamudu HM, et al. Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress. Environ Res, 2021; 196, 110361. doi:  10.1016/j.envres.2020.110361
[23] Zhang B, Zhai FY, Du SF, et al. The China health and nutrition survey, 1989-2011. Obes Rev, 2014; 15, 2−7.
[24] You L, Kou J, Wang MD, et al. An exposome atlas of serum reveals the risk of chronic diseases in the Chinese population. Nat Commun, 2024; 15, 2268. doi:  10.1038/s41467-024-46595-z
[25] Ren ZY, Luo S, Liu L. The positive association between white blood cell count and metabolic syndrome is independent of insulin resistance among a Chinese population: a cross-sectional study. Front Immunol, 2023; 14, 1104180. doi:  10.3389/fimmu.2023.1104180
[26] Lv MR, Su C, Huang FF, et al. Combined impact of elevated C-reactive protein levels and dyslipidemia on stroke: a CHNS prospective cohort study. Front Public Health, 2024; 12, 1435004. doi:  10.3389/fpubh.2024.1435004
[27] Gao Q, Lin YX, Xu RQ, et al. Positive association of triglyceride-glucose index with new-onset hypertension among adults: a national cohort study in China. Cardiovasc Diabetol, 2023; 22, 58. doi:  10.1186/s12933-023-01795-7
[28] Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis, 2010; 42, 503−8. doi:  10.1016/j.dld.2009.08.002
[29] Yang M, Su WT, Li HR, et al. Association of per- and polyfluoroalkyl substances with hepatic steatosis and metabolic dysfunction-associated fatty liver disease among patients with acute coronary syndrome. Ecotoxicol Environ Saf, 2023; 264, 115473. doi:  10.1016/j.ecoenv.2023.115473
[30] Carrico C, Gennings C, Wheeler DC, et al. Characterization of weighted quantile sum regression for highly correlated data in a risk analysis setting. J Agric Biol Environ Stat, 2015; 20, 100−20. doi:  10.1007/s13253-014-0180-3
[31] Park B, Kim B, Kim CH, et al. Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: a population-based study in Korea. Ecotoxicol Environ Saf, 2024; 276, 116310. doi:  10.1016/j.ecoenv.2024.116310
[32] Yu LL, Liu W, Wang X, et al. A review of practical statistical methods used in epidemiological studies to estimate the health effects of multi-pollutant mixture. Environ Pollut, 2022; 306, 119356. doi:  10.1016/j.envpol.2022.119356
[33] Lei RY, Xue BD, Tian XY, et al. The association between endocrine disrupting chemicals and MAFLD: evidence from NHANES survey. Ecotoxicol Environ Saf, 2023; 256, 114836. doi:  10.1016/j.ecoenv.2023.114836
[34] Liu Q, Fan GJ, Bi JN, et al. Associations of polychlorinated biphenyls and organochlorine pesticides with metabolic dysfunction-associated fatty liver disease among Chinese adults: effect modification by lifestyle. Environ Res, 2024; 240, 117507. doi:  10.1016/j.envres.2023.117507
[35] Sun JH, Yang SQ, Zhang Y, et al. Relationship between phthalates exposures and metabolic dysfunction-associated fatty liver disease in United States adults. PLoS One, 2024; 19, e0301097. doi:  10.1371/journal.pone.0301097
[36] Huang J, Wang QY, Liu S, et al. Comparative chronic toxicities of PFOS and its novel alternatives on the immune system associated with intestinal microbiota dysbiosis in adult zebrafish. J Hazard Mater, 2022; 425, 127950. doi:  10.1016/j.jhazmat.2021.127950
[37] Ribeiro E, Ladeira C, Viegas S. EDCs mixtures: a stealthy hazard for human health? Toxics, 2017; 5, 5.
[38] Bertolotti M, Lonardo A, Mussi C, et al. Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol, 2014; 20, 14185−204. doi:  10.3748/wjg.v20.i39.14185
[39] Li XT, Wang Y, Qian CJ, et al. Perfluoroalkyl acids (PFAAs) in urban surface water of Shijiazhuang, China: occurrence, distribution, sources and ecological risks. J Environ Sci (China), 2023; 125, 185−93. doi:  10.1016/j.jes.2022.01.031
[40] Wu YQ, Cheng ZY, Zhang W, et al. Association between per- and poly-fluoroalkyl substances and nonalcoholic fatty liver disease: a nested case-control study in Northwest China. Environ Pollut, 2024; 350, 123937. doi:  10.1016/j.envpol.2024.123937
[41] Britton LJ, Subramaniam VN, Crawford DH. Iron and non-alcoholic fatty liver disease. World J Gastroenterol, 2016; 22, 8112−22. doi:  10.3748/wjg.v22.i36.8112
[42] Tan L, Zhou QY, Liu J, et al. Association of iron status with non-alcoholic fatty liver disease and liver fibrosis in US adults: a cross-sectional study from NHANES 2017-2018. Food Funct, 2023; 14, 5653−62. doi:  10.1039/D2FO04082D
[43] Yang W, Ling X, He SJ, et al. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: an integrated approach. Environ Int, 2023; 178, 108138. doi:  10.1016/j.envint.2023.108138
[44] Zhang J, Wang KX, Guo J, et al. Study on the mechanism of liver toxicity induced by acenaphthene in zebrafish. Ecotoxicol Environ Saf, 2023; 249, 114441. doi:  10.1016/j.ecoenv.2022.114441
[45] Ruddell RG, Hoang-Le D, Barwood JM, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology, 2009; 49, 887−900. doi:  10.1002/hep.22716
[46] Mostafalou S. Persistent organic pollutants and concern over the link with insulin resistance related metabolic diseases. In: Gunther FA, De Voogt P. Reviews of Environmental Contamination and Toxicology Volume 238. Springer. 2016, 69-89.
[47] Fang L, Guo JJ, Wang Q, et al. Chronic exposure to environmental level phenanthrene induces non-obesity-dependent insulin resistance in male mice. Environ Sci Technol, 2020; 54, 15225−34. doi:  10.1021/acs.est.0c04171
[48] Kim CH, Kim HK, Bae SJ, et al. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism, 2011; 60, 414−20. doi:  10.1016/j.metabol.2010.03.007
[49] Ma H, Lin HD, Hu Y, et al. Serum ferritin levels are associated with insulin resistance in Chinese men and post-menopausal women: the Shanghai Changfeng study. Br J Nutr, 2018; 120, 863−71. doi:  10.1017/S0007114518002167
[50] Sen P, Fan Y, Schlezinger JJ, et al. Exposure to environmental toxicants is associated with gut microbiome dysbiosis, insulin resistance and obesity. Environ Int, 2024; 186, 108569. doi:  10.1016/j.envint.2024.108569
[51] Velmurugan G, Ramprasath T, Gilles M, et al. Gut microbiota, endocrine-disrupting chemicals, and the diabetes epidemic. Trends Endocrinol Metab, 2017; 28, 612−25. doi:  10.1016/j.tem.2017.05.001